Skip to main content

Web Exclusives

Rybrevant First FDA-Approved Therapy for NSCLC with EGFR Exon 20 Insertion Mutations

Lumakras First FDA-Approved Therapy for Advanced or Metastatic NSCLC with KRAS G12C Mutation

Zynlonta First FDA-Approved CD19-Directed Therapy for Large B-Cell Lymphoma

Zanidatamab Shows Promising Activity in Patients with HER2-Overexpressing Gastric Cancers

Wayne Kuznar

Prostate Cancer

¹⁷⁷Lu-PSMA-617 Superior to Cabazitaxel in Metastatic Prostate Cancer

Phoebe Starr

Lung Cancer, Infectious Diseases, Oncology

Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care

Walter Alexander

Lung Cancer, Oncology

EGFR Most Common Mutation in Women with Lung Cancer and No Smoking History

Walter Alexander

Breast Cancer, Oncology

Sacituzumab Govitecan Improves Progression-Free Survival in Metastatic Triple-Negative Breast Cancer with Brain Metastases

Phoebe Starr

Breast Cancer, Oncology

First-Line Pembrolizumab plus Chemotherapy Extend Progression-Free Survival in Patients with Metastatic Triple-Negative Breast Cancer

Phoebe Starr

Cosela First CDK4/6 Inhibitor FDA Approved to Reduce Chemotherapy-Induced Myelosuppression

Page 13 of 37
Results 121 - 130 of 364